BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«KIR2DL5

Below is an extended KIR2DL5 research listing. Click here to return to the KIR2DL5 main in depth entry.

Recent Publications on KIR2DL5:

Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease.
INTRODUCTION: An emerging body of evidence is accumulating to suggest that...
Direct Link
24th September, 2008
Central Laboratory, Shandong Provincial Hospital, Shandong University,
Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5.
Human killer cell immunoglobulin-like receptor (KIR) genes are important...
Direct Link
6th September, 2008
Northern Ireland Regional Histocompatibility and Immunogenetics
Promoter variants of KIR2DL5 add to diversity and may impact gene expression.
Sequencing of polymerase chain reaction (PCR)-amplified genomic DNA...
Direct Link
30th August, 2008
Georgetown University Medical Center, Washington, DC, USA.
Activating KIR genes are associated with ankylosing spondylitis in Asian populations.
Killer cell immunoglobulin-like receptors (KIRs) and human leukocyte...
Direct Link
22nd July, 2008
Department of Immunology, Hospital Universitario Central de Asturias,
KIR2DL5 alleles mark certain combination of activating KIR genes.
Killer cell Ig-like receptors (KIR) control the immune response of NK...
Direct Link
30th May, 2008
Department of Pathology and Laboratory Medicine, UCLA Immunogenetics
Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes.
The KIR2DS3 gene is an activating homologue of the inhibitory killer-cell...
Direct Link
16th May, 2008
Servicio de Inmunologia, Hospital Universitario Puerta de Hierro, Madrid,
Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. 11th January, 2008
Department of Center Laboratory, Shandong Provincial Hospital, Shandong
Epigenetic silencing of potentially functional KIR2DL5 alleles: Implications for the acquisition of KIR repertoires by NK cells.
NK cells detect altered patterns of HLA expression in infections and...
Direct Link
15th September, 2007
Servicio de Inmunologia, Hospital Universitario Puerta de Hierro, Madrid,
High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.
The killer cell immunoglobulin-like receptors (KIR) interact with major...
Direct Link
24th August, 2007
Center for Genetics, Children's Hospital Oakland Research Institute, 5700
KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.
In natural killer cells, killer immunoglobulin-like receptors (KIRs) loci...
Direct Link
28th June, 2007
Laboratorio de Inmunogenetica, Hospital de Clinicas, Facultad de Medicina,
Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
Understanding the complex interaction between human leukocyte antigen...
Direct Link
22nd June, 2007
Department of Immunology & Immunogenetics, Instituto de Diagnostico y
Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. 20th June, 2007
Servicio de Inmunologia, Hospital Universitario Puerta de Hierro, San
Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes.
Using polymerase chain reaction (PCR)-based sequence-specific primers, the...
Direct Link
5th June, 2007
Padua University School of Medicine, Department of Clinical and
Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.
Genome-wide scans have detected linkage to celiac disease (CD) in several...
Direct Link
17th May, 2007
Endocrinology and Diabetes Research Group, Hospital de Cruces, Barakaldo,
KIR haplotype content at the allele level in 77 Northern Irish families.
There has been an explosion in population studies determining the...
Direct Link
28th March, 2007
Northern Ireland Regional Histocompatibility and Immunogenetics
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional